Marcus Schulz - 03 Aug 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Chief Revenue Officer
Signature: /s/ Marcus Schulz
Issuer symbol: BLFS
Transactions as of: 03 Aug 2022
Net transactions value: -$92,138
Form type: 4
Filing time: 05 Aug 2022, 20:00:45 UTC
Previous filing: 26 Jul 2022
Next filing: 11 Aug 2022
SEC: View on sec.gov

Quoteable Key Fact

"Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 05 Aug 2022."

Quick Takeaways

This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 05 Aug 2022, 20:00.

What Changed

Previous filing in this sequence was filed on 26 Jul 2022.
Current net transaction value: -$92,138.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock	Sale	$92,138	-4,600	-11%	$20.03	36,218	03 Aug 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of June 14, 2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.06, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of June 14, 2022.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.06, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.